Screener
Eligibility screening
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia
3 US sites in CA, MD, WI
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia
3 US sites in CA, MD, WI
Before we begin
Your answer affects how the questions are phrased.